Skip to main content

Table 10 (abstract P223). Demographic and baseline characteristics of the treatment groups

From: 37th International Symposium on Intensive Care and Emergency Medicine (part 2 of 3)

Variable

Citicoline WNH (N = 67)

Control Austrian centers (N = 67)

p

Sex, N (% male)

52 (78%)

50 (75%)

0.839

ISS, mean (SD)

27.4 (12.4)

31.7 (17.3)

0,1

Total GCS assessed at admission, mean (SD)

6.4 (4.7)

6.0 (4.2)

0.662

Pupillary reactivity in field, N (%)

  

0.702

Both reactive

41 (61%)

36 (54%)

 

One reactive

2 (3%)

2 (3%)

 

None reactive

3 (5%)

6 (9%)

 

Unknown

21 (31%)

23 (34%)

 

Pupillary reactivity at admission, N (%)

  

0.416

Both reactive

28 (42%)

29 (43%)

 

One reactive

2 (3%)

5 (8%)

 

None reactive

1 (2%)

3 (5%)

 

Unknown

36 (54%)

30 (45%)

 

Rotterdam CT score, N (%)

  

0.052

1

2 (3%)

2 (3%)

 

2

22 (34%)

19 (31%)

 

3

31 (48%)

17 (28%)

 

4

7 (11%)

19 (31%)

 

5

2 (3%)

3 (5%)

 

6

0

1 (2%)

 

Subarachnoid hemorrhage, N (% Yes)

39 (58%)

41 (61%)

0.861

Epidural hematoma, N (% Yes)

8 (12%)

13 (19%)

0,342

Subdural hematoma, N (% Yes)

37 (55%)

43 (64%)

0.379

Prehospital hypotension, N (% Yes)

1 (2%)

4 (6%)

0.328

Prehospital hypoxia, N (% Yes)

5 (8%)

12 (18%)

0.19

Prehospital intubation, N (% Yes)

33 (49%)

40 (60%)

0.057

Predicted six months mortality, mean % (SD)

30.7% (18.6)

33.4% (21.7)

0.682

Predicted six months unfav. outcome, mean % (SD)

51.8% (21.6)

53.9% (23.7)

0.626